A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

Growing interest in CIK cell therapy highlights challenges. Creative Biolabs supports researchers with CAR-CIK ...

Greenwich LifeSciences is a single-asset biotech focused on GLSI-100, an immunotherapy for HER2-positive breast cancer. Learn ...

The Central Bureau of Investigation (CBI), which is probing the NEET-UG 2026 paper leak to identify a network of conspirators ...

Eli Lilly has agreed to buy a Peter Thiel-backed psychedelic drug developer for up to $3.8bn, as the world’s most valuable ...

Recent developments in the NEET paper leak case reveal that Shivraj Motegaonkar, a coaching centre owner arrested by the CBI, ...

Cannara Biotech (TSX:LOVE) released third-quarter financial results and hosted an earnings call on Wednesday. Read the ...

C11 antibody builds on APOE Christchurch variant biology associated with resilience to Alzheimer’s disease, including effects ...

AI is rapidly reshaping biomedical research, but practitioners agree that AI’s success depends on more than advanced algorithms.

Shares of Q32 Bio (NASDAQ: QTTB) soared on Monday after the biotechnology company announced promising clinical trial results ...

The U.S. IPO market is on track to set new records in 2026, bolstered by SpaceX’s recent $75 billion IPO, which marked the ...

Abbott (ABT) outpaced Danaher (DHR) as FreeStyle Libre delivered $2.08B while Cepheid respiratory revenue fell 25% on a soft flu season. Danaher's bioprocessing equipment orders surged over 30%, ...